Skip to content

Effects of Muscle Cooling on Motor Unit Firing of the Quadriceps

Effects of Muscle Cooling on Motor Unit Firing of the Quadriceps: A Pilot Feasibility Study

Status
Suspended
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07381920
Acronym
CRYO
Enrollment
24
Registered
2026-02-02
Start date
2026-01-20
Completion date
2027-05-01
Last updated
2026-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

muscle cooling, motor unit behavior, HDsEMG, Quadriceps

Brief summary

The overall objective of this pilot study is to establish the feasibility and methodological validity of using high-density surface electromyography to characterize motor unit behavior of the quadriceps under thermoneutral and locally cooled conditions, and to generate preliminary data to inform the design of a larger, hypothesis-driven study.

Detailed description

This randomized, cross-over pilot study will recruit 24 healthy young adults (12 men and 12 women) between the ages of 18 and 35 years. Participants will attend two in-person laboratory visits separated by a minimum of 48 hours. Visit 1 will include informed consent, eligibility confirmation, baseline assessments, and familiarization procedures. Visit 2 will include experimental testing under thermoneutral and cooled conditions.

Interventions

PROCEDURECryotherapy

For the cold condition, an Aircast Thigh Pad (Aircast), connected to the Cryo Cuff IC cooler (DJO Global, Vista, California, USA) will be applied to the dominant thigh. The system circulates ice water maintained at approximately 10-15°C with intermittent compression. Cooling duration will be individualized based on mid-thigh skinfold thickness, consistent with published recommendations that account for the effect of subcutaneous tissue on intramuscular cooling9. Participants with a mid-thigh skinfold thickness of 0-10 mm will receive 10 minutes of cooling; those with a skinfold thickness of 11-20 mm will receive 25 minutes of cooling; those with a skinfold thickness of 21-30 mm will receive 40 minutes of cooling; and those with a skinfold thickness of 31-40 mm will receive 60 minutes of cooling. Participants will remain seated for the duration of the cooling treatment.

Sponsors

Wake Forest University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Men and women between the ages of 18 and 35 years * Healthy adults, defined as absence of significant acute/chronic medical condition, injury, and/or illness that may compromise subject safety, limit the ability of the participant to complete the study, and/or compromise the objectives of the study as determined by the Principal Investigator.

Exclusion criteria

* Current diagnosis or history of: * major metabolic disease (e.g., type I and type II diabetes), * neuromuscular disease (e.g., cervical spondylotic radiculomyelopathy, lumbar spondylosis, amyotrophic lateral sclerosis, Guillain-Barré syndrome, and acquired demyelinating polyneuropathies), * cardiovascular disease (e.g., stage II hypertension, heart failure, myocardial infarction/ischemia, peripheral vascular disease, Raynaud's phenomenon, or other conditions associated with impaired peripheral circulation), * significant myocardial or pericardial diseases (e.g. amyloidosis, constriction), * moderate or severe valvular disease, * pulmonary/respiratory disease (e.g., asthma, chronic bronchitis, emphysema, chronic obstructive pulmonary disease), * cancer, * renal disease, * liver disease, * or anemia. * Current or recent musculoskeletal injury (e.g. fracture, sprain, dislocation) or any physical disability that precludes safe and adequate testing. * Pregnancy or breastfeeding. * Thigh circumference greater than 23 inches * Mid-thigh skinfold thickness greater 40 mm

Design outcomes

Primary

MeasureTime frameDescription
Motor Unit (MU) YieldImmediately after the interventionNumber of unique motor units successfully identified (decomposed) from quadriceps HDsEMG recordings during maximal voluntary contractions (MVCs) under thermoneutral and cooled conditions.
HDsEMG Decomposition AccuracyImmediately after the interventionQuality/accuracy of motor unit decomposition from quadriceps HDsEMG recorded during MVCs under thermoneutral and cooled conditions, based on decomposition quality metrics generated by the Delsys Neuromap Precision Decomposition III algorithm.
Proportion of Analyzable MVC TrialsImmediately after the interventionPercentage of MVC trials that yield HDsEMG data suitable for motor unit decomposition and analysis under thermoneutral and cooled conditions (successful decomposition and acceptable signal quality).

Secondary

MeasureTime frameDescription
Slope of MUAP-FR relationshipImmediately after the interventionSlope of the linear regression relating MU firing rate to MU action potential amplitude during MVCs under thermoneutral and cooled conditions.
Y-intercept of MUAP-FR relationshipImmediately after the interventionY-intercept of the linear regression relating MU firing rate to MU action potential amplitude during MVCs under thermoneutral and cooled conditions.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 22, 2026